Breckenridge, Ferrex 150, Iron Complex - 100 Unit Dose Capsules

This product may be used for the dietary management of iron deficiencies. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Directions: Usual adult dosage is one or two capsules daily or as directed by a physician or health care provider. Do not exceed recommended dosage. Store at 25 degrees C (77 degrees F); excursions permitted to 15-30 degrees C (59-86 degrees F). Protect from light and moisture. Do not use if blister seals are broken.

Ingredients: Serving Size 1 Capsule: Iron (Elemental) (as Polysaccharide-Iron) 150 mg (833% Daily Value); Sodium Lauryl Sulfate; Gelatin; Microcrystalline Cellulose; Stearic Acid; Polyethylene Glycol; Citric Acid; Croscarmellose Sodium; Titanium Dioxide; Polyvinylpyrrolidone; FD&C Yellow No. 5 Lake (Tartrazine, as a Color Additive); FD&C Red No. 40 Lake; FD&C Red No. 3 Lake; FD&C Blue No. 1 Lake

Warnings: CONTRAINDICATIONS: Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons). Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity. The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systematic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible. As with all oral iron preparations, Ferrex 150 should be stored out of the reach of children to protect against accidental iron poisoning. Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools. Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other. If pregnant, or planning to become pregnant or are currently breast-feeding, please contact your physician or health-care provider before using or continuing use. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. ADVERSE REACTIONS: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient. OVERDOSE: The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma. To report a serious adverse event contact 1-800-367-3395.

Disclaimer:

The information provided here at TheOnlineDrugStore is strictly to be used for informational purposes only. The Online Drugstore does not represent or warrant the product details, ingredients and nutritional value, and any other product information to be accurate or complete. Occasionally manufacturers improve or change their product formulas, update labels, and change their packaging. The images presented are also for reference only and may differ from the actual product received. It is recommended that you do not solely rely on the information displayed on this site. For any specific product info or concerns it is recommended that you contact the manufacturer directly. If there are healthcare concerns or questions, please contact your licensed healthcare professional for advice.